Argenx
ARGX
#570
Rank
ยฃ29.03 B
Marketcap
ยฃ484.10
Share price
-0.80%
Change (1 day)
34.30%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Argenx (ARGX) - Total assets

Total assets on the balance sheet as of June 2024 : ยฃ3.79 Billion

According to Argenx 's latest financial reports the company's total assets are ยฃ3.79 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Argenx - Total assets on balance sheet (from 2021 to 2020)

Total assets by year

Year Total assets Change
2022-12-31ยฃ2.59 B22.69%
2021-12-31ยฃ2.11 B2.66%
2020-12-31ยฃ2.05 B49.53%
2019-12-31ยฃ1.37 B130.67%
2018-12-31ยฃ0.59 B50.96%
2017-12-31ยฃ0.39 B316.6%
2016-12-31ยฃ94.82 M155.77%
2015-12-31ยฃ37.07 M-33.29%
2014-12-31ยฃ55.57 M92.2%
2013-12-31ยฃ28.91 M54.1%
2012-12-31ยฃ18.76 M-29.68%
2011-12-31ยฃ26.68 M152.61%
2010-12-31ยฃ10.56 M